SELF-TEST FOR SARS-COV-2 ANTIGEN (CORONAVIRUS) - ANVISA Registration 80859840213

Access comprehensive regulatory information for SELF-TEST FOR SARS-COV-2 ANTIGEN (CORONAVIRUS) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80859840213 and manufactured by TIANJIN BIOSCIENCE DIAGNOSTICS TECHNOLOGY CO., LTD.. The registration is held by CPMH - Comércio e Indústria de Produtos Médico-Hospitalares e Odontológicos LTDA. with validity until Feb 17, 2032.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including HANGZHOU ALLTEST BIOTECH CO. LTD, GENRUI BIOTECH INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.